Rivernorth Capital Management’s PepperLime Health Acquisition Corporation Warrrant PEPLW Stock Holding History

Rivernorth Capital Management’s Portfolio PEPLW Stock Details PEPLW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-200,000	Closed	-$60	–	476
2024 Q1	$60	Sell	200,000 -542,500	-73%	-$8.25K	﹤0.01%	462
2023 Q4	$22.3K	Hold	742,500	–	–	﹤0.01%	286
2023 Q3	$52.7K	Hold	742,500	–	–	﹤0.01%	294
2023 Q2	$15K	Hold	742,500	–	–	﹤0.01%	391
2023 Q1	$70.6K	Hold	742,500	–	–	﹤0.01%	376
2022 Q4	$14.8K	Hold	742,500	–	–	﹤0.01%	525
2022 Q3	$37K	Hold	742,500	–	–	﹤0.01%	594
2022 Q2	$119K	Hold	742,500	–	–	﹤0.01%	535
2022 Q1	$304K	Hold	742,500	–	–	0.01%	508
2021 Q4	$334K	Buy	+742,500	New	+$351K	0.01%	432

Rivernorth Capital Management's PEPLW Position: Q2 2024 in Review

Rivernorth Capital Management sold out of PepperLime Health Acquisition Corporation Warrrant (PEPLW) in Q2 2024, closing a stake of 200,000 shares — an estimated $60 sold.

Rivernorth Capital Management first reported a position in PEPLW in Q4 2021 and held it in 10 quarters. The position peaked at $334K in Q4 2021. 0 funds tracked by Wall St. Rank hold PEPLW as of Q2 2024.

Rivernorth Capital Management reported no remaining PepperLime Health Acquisition Corporation Warrrant position as of Q2 2024 after selling out during the quarter.
Rivernorth Capital Management sold 200,000 PepperLime Health Acquisition Corporation Warrrant shares in Q2 2024, an estimated $60.
Rivernorth Capital Management first reported a position in PepperLime Health Acquisition Corporation Warrrant in Q4 2021 and held it in 10 quarters.
Rivernorth Capital Management's PepperLime Health Acquisition Corporation Warrrant position peaked at $334K in Q4 2021.
0 funds tracked by Wall St. Rank held PepperLime Health Acquisition Corporation Warrrant as of Q2 2024.

Based on Rivernorth Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.